Hims & Hers Health (HIMS) Amortizatization of Intangibles (2020 - 2026)
Hims & Hers Health's (HIMS) quarterly Amortizatization of Intangibles came in at $242000.0 in Q1 2026, down 65.08% year-on-year from $693000.0 in Q1 2025, and down 66.34% quarter-over-quarter from $719000.0 in Q4 2025.
Hims & Hers Health (HIMS) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Amortizatization of Intangibles across 7 years of filings, most recently posting $242000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $242000.0, down 65.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (down 60.19% YoY), and the FY2025 annual result was $2.0 million, down 53.34% from the prior year.
- Amortizatization of Intangibles came in at $242000.0 for Q1 2026 at Hims & Hers Health, down from $719000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.7 million in Q4 2023 to a low of -$971000.0 in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $840000.0 (2022), against an average of $715823.5.
- Across the five-year window, Amortizatization of Intangibles slumped 238.33% in 2022 and jumped 1333.33% in 2023, its largest moves.
- Hims & Hers Health's Amortizatization of Intangibles stood at $840000.0 in 2022, then jumped by 96.67% to $1.7 million in 2023, then sank by 44.61% to $915000.0 in 2024, then declined by 21.42% to $719000.0 in 2025, then tumbled by 66.34% to $242000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $242000.0 (Q1 2026), $719000.0 (Q4 2025), and $253000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 242,000.00 |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 242,000.00 |
| Mar 31, 2026 | 242,000.00 |
| Dec 31, 2025 | 719,000.00 |
| Dec 31, 2025 | 719,000.00 |
| Sep 30, 2025 | 253,000.00 |
| Sep 30, 2025 | 253,000.00 |
| Jun 30, 2025 | 367,000.00 |
| Jun 30, 2025 | 367,000.00 |
| Mar 31, 2025 | 693,000.00 |
| Mar 31, 2025 | 693,000.00 |
| Dec 31, 2024 | 915,000.00 |
| Dec 31, 2024 | 915,000.00 |
| Sep 30, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.16 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.08 Mn |
| Mar 31, 2024 | 1.08 Mn |
| Dec 31, 2023 | 1.65 Mn |
| Dec 31, 2023 | 1.65 Mn |